Call for Papers
(Specific to Pharmaceutical Sciences)
Approaches for targeted protein degradation: From biology to drug development
Authors Guide:
A wide range of studies on the topic, including those dealing with molecular and structural biology, medicinal chemistry, and pharmaceutical development, may be collected in the special issue on targeted protein degradation. (Dr. Christoph Saal, Darmstadt-based Merck Group Prof. Carlos Galdeano, University of Barcelona; Dr Catherine Lindon, University of Cambridge)
Submission:
Submission of Original research papers, reviews, mini-reviews, comments, and brief commutations are all solicited.
Protein Degradation
Targeted protein degradation is a new therapy approach that is quickly gaining traction. Proteins are destroyed selectively by the cell's endogenous ubiquitin-proteasome system. The formation of a ternary complex between the protein to be degraded, an E3 ligase that carries out ubiquitinylation of the targeted protein, and a molecule that links the protein to be degraded and the E3 ligase, such as proteolysis targeting chimeras (Protacs) or molecular glues, initiates targeted protein degradation. Compared to well-established therapeutic principles such as target protein inhibition, targeted protein degradation provides a fundamentally different strategy. This special issue presents developments and problems in targeted protein degraders across fields such as biology, chemistry, and pharmaceutical development. The special issue on targeted protein degradation aims to collect a diverse range of research on the subject, including those relevant to molecular and structural biology, medicinal chemistry, and pharmaceutical development.
Pubrica Offers:
Pubrica offers assistance when creating a clinical case report for a rare condition. You may get whole publishing assistance from Pubrica for a range of periodicals, books, and publications. We offer full support, helping you with everything from your first concept to a sharp report. We will also be there for you during the whole publishing process. We support medical professionals, students, hospitals, pharma and device makers in their search for a reliable writing partner. We have professionals in various fields, including life science, medicine, and technology. We can publish in journals with high impact factors because of our reliable, high-quality writing, including Annual Review of Pharmacology and Toxicology, Pharmacological Reviews, Trends in Pharmacological Sciences, Pharmacology & Therapeutics, Clinical Pharmacology & Therapeutics, Neuropsychopharmacology, Reviews of Physiology Biochemistry and Pharmacology, and Alimentary Pharmacology & Therapeutics.
